相关实验视频
Updated: Jan 10, 2026

08:01
The Soft Agar Colony Formation Assay
Published on: October 27, 2014
113.5K
通过调节酸盐与尿酸盐比率 (PUR),CXCL10促进非小细胞肺癌 (NSCLC) 的进展
1Thoracic Surgery Department , Qianjiang Central Hospital of Hubei Province , 433100, Qianjiang, China.
Discover oncology
|November 24, 2025
概括
高CXCL10基因表达通过调节PUR增加非小细胞肺癌 (NSCLC) 风险. 这一发现提供了对NSCLC机制和潜在治疗点的见解.
科学领域:
- 遗传学和分子生物学
- 在瘤学瘤学.
- 代谢学 代谢学 代谢学
背景情况:
- 非小细胞肺癌 (NSCLC) 的发病过程涉及复杂的遗传和代谢相互作用.
- 了解基因-代谢物-疾病因果途径对于确定新的治疗点至关重要.
研究的目的:
- 使用孟德尔随机化 (MR) 研究与NSCLC相关的基因,代谢物和NSCLC之间的因果关系.
- 阐明CXCL10在NSCLC发育中的作用背后的分子机制.
- 探索CXCL10作为NSCLC生物标志物的潜力.
主要方法:
- 使用两个样本的门德尔随机化 (MR) 分析与来自芬根数据库的NSCLC GWAS数据.
- 来自eQTLGen和pQTL数据库的综合基因表达数据.
- 使用来自GEO数据库的NSCLC表达数据进行了差异基因表达分析和调解分析.
主要成果:
- 在高表达CXCL10基因和增加NSCLC风险之间发现了显著的积极因果关系.
- 调解分析显示,CXCL10通过调节PUR代谢物来促进NSCLC的发展.
- 量化了调解效应 (0.039),调解比例为25.4% (P=0.012).
结论:
- CXCL10在NSCLC的发展中发挥着重要作用,可能通过调节PUR.
- 这些发现为NSCLC的分子机制提供了新的见解.
- CXCL10成为针对性NSCLC治疗的潜在生物标志物.
相关概念视频
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K

